Exploring the "regulatory code" in cells: the palmitoylation of TEAD proteins and the mystery of cancer

Exploring the "regulatory code" in cells: the palmitoylation of TEAD proteins and the mystery of cancer

In the microscopic world of the human body, cells are like busy construction workers, building our bodies according to a set of precise "blueprints". Among them, the Hippo signaling pathway is a set of crucial "construction guidelines", which is responsible for controlling the size of organs, preventing excessive cell growth, and thus avoiding the occurrence of tumors. Today, we are going to unveil the mystery of TEAD proteins, a key role in the Hippo pathway, and its intricate connection with cancer.

TEAD proteins and the "baton" of the Hippo pathway

The Hippo pathway is like a "traffic light" for cell growth. It tells cells when to grow and when to stop through a series of complex signal transmissions. In this pathway, TEAD proteins play the role of "batons". It can bind to two co-activators, YAP and TAZ, to regulate gene expression, thereby affecting cell growth and organ size. If the regulatory function of TEAD protein is abnormal, cell growth will be out of control, just like traffic lights fail and vehicles are in chaos, which may eventually lead to the formation of tumors.

Palmitoylation: the "mysterious modification" of TEAD protein

In the process of studying TEAD protein, scientists have discovered an interesting phenomenon - TEAD protein can undergo a special modification called palmitoylation. Palmitoylation is a post-translational modification of protein. Simply put, a fatty acid chain called palmitoyl is added to the protein. This modification can change the structure and function of the protein, just like putting on different "coats" for the protein, allowing it to play different roles in the cell.

Previously, scientists believed that palmitoylation was mainly completed by an enzyme called PATs (palmitoyl acyltransferase). However, a recent study published in the journal Nature Chemical Biology found that palmitoylation of TEAD protein does not require the participation of PATs, but is completed by its own ability in a high concentration of palmitoyl-CoA (palmitoyl coenzyme A) environment. This phenomenon is called self-palmitoylation. Moreover, this self-palmitoylation does not occur randomly, it occurs specifically on some specific cysteine ​​residues on TEAD proteins.

How does palmitoylation affect TEAD proteins?

In order to gain a deeper understanding of the impact of palmitoylation on TEAD proteins, scientists designed a special probe that can find all palmitoylated proteins in cells like a "detective". In this way, they found that the palmitoylation site of TEAD proteins is very special, and the palmitoylate chain is embedded in a hydrophobic cavity inside the TEAD protein. This hydrophobic cavity is like a "small pocket" that tightly wraps the palmitoylate chain inside. This structure makes the conformation of TEAD protein more stable, just like putting on a "tights" for it, making its function in the cell more stable and efficient.

The connection between TEAD proteins and cancer

So, what is the relationship between palmitoylation of TEAD proteins and cancer? It turns out that the content of palmitoyl-CoA in cells is closely related to the palmitoylation of TEAD proteins. And the synthesis of palmitoyl-CoA is inseparable from an enzyme called FASN (fatty acid synthase). FASN is like a "factory" in the cell, responsible for synthesizing palmitoyl-CoA. Interestingly, FASN is closely related to the occurrence of cancer. In many cancer cells, the activity of FASN is very high, resulting in an increase in the content of palmitoyl-CoA in the cell. This provides more "raw materials" for the palmitoylation of TEAD proteins, which enhances the activity of TEAD proteins, which may lead to excessive cell growth and tumor occurrence.

From TEAD proteins to anticancer drugs

This study not only gives us a deeper understanding of the palmitoylation of TEAD proteins, but also brings new hope for the development of anticancer drugs. Scientists have found that the hydrophobic cavity inside the TEAD protein is the key area for palmitoylation. If a small molecule drug can be developed that can specifically bind to this hydrophobic cavity and prevent palmitoylation from occurring, it may inhibit the activity of TEAD proteins, thereby preventing excessive cell growth and achieving an anti-cancer effect.

In short, the palmitoylation of TEAD proteins is a very important regulatory mechanism in cells. It not only affects the normal function of the Hippo pathway, but also has a close relationship with the occurrence of cancer. By deeply studying the palmitoylation of TEAD proteins, we can not only better understand the regulatory mechanism of cell growth, but also provide important clues for the development of new anti-cancer drugs. Let us look forward to more breakthroughs by scientists in this field, bringing more hope to human health!